ghk-cu human clinical trial / KPV · Disguised Alpha GHK-Cu Research Peptide Australia |
Description
GH secretagogues + GLP-1 agonists
This is related to copper sensitivity in some patients
Due to the poor bioavailability and interconversion of these precursors, more potential NAD + precursors and intervention strategies are sought that have higher potency and stability
How does it help with fat loss
